Research for Innovative Care

Opioids

Healing or Harming? The Biochemical Consequences of Controlled Substance Medications

Brent E Boyett, DMD, DO, DFASAM

Beta-Arrestin-Mediated Downregulation of μ-Opioid and Dopamine Receptors: Implications for Tolerance, Opioid-Induced Hyperalgesia, and the Opponent Process in Addiction

Grace Willoughby, DO

Clinical Policy: Management of Patients on Controlled Substances under Treatment Agreement

Brent E Boyett, DMD, DO, DFASAM

ASAM Clinical Pearls; Dr. Boyett discusses the use of ketamine in the treatment of addiction with the president of American Society of Addiction Medicine.

Brent E Boyett, DMD, DO, DFASAM

Breaking Patterns; Chapter 2: Preparing for the Ketamine Experience

Brent E Boyett, DMD, DO, DFASAM

Breaking Patterns; Chapter 1: Understanding Ketamine Therapy

Brent E Boyett, DMD, DO, DFASAM

Breaking Patterns, How ketamine Resets Your Thoughts

Brent E Boyett, DMD, DO, DFASAM

What to Expect During Your Therapeutic Ketamine Infusion

Brent E Boyett, DMD, DO, DFASAM

Preparing for the Ketamine Experience

Brent E Boyett, DMD, DO, DFASAM

Understanding Ketamine Therapy

Brent E Boyett, DMD, DO, DFASAM